Immucell (ICCC) Gross Margin (2010 - 2026)
Immucell's Gross Margin came in at 33.92% for Q2 2026, down 9.81 percentage points from 43.72% a year earlier.
Powered by 
Analysis
Immucell (ICCC) Gross Margin (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Immucell reported Gross Margin of 39.34%, up 1.90 percentage points year-over-year; for FY2025, it came in at 41.40%, up 11.43 percentage points from FY2024.
- Gross Margin carries a five-year change of -3.33 percentage points (FY2020 to FY2025).
- Going back by year, Gross Margin was 29.97% in FY2024 (+7.83 pp), 22.15% in FY2023 (-19.05 pp), 41.19% in FY2022 (-3.79 pp) and 44.98% in FY2021 (+0.25 pp).
- The Q2 2026 figure represents the lowest quarterly Gross Margin since Q3 2024.
- Year-over-year, Gross Margin increased in five of the last six quarters, with an average year-over-year change of +7.08 percentage points.
- The fastest year-over-year change in Gross Margin over five years came in Q1 2024 (a gain of 22.90 percentage points), and the weakest in Q1 2023 (a drop of 43.00 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,133.99 Bn | 1,102.58 Bn | 19.71 Bn | 85.78% |
| 2 | Johnson & Johnson | 615.70 Bn | 534.23 Bn | 17.26 Bn | 68.19% |
| 3 | AbbVie | 501.05 Bn | 474.16 Bn | 12.70 Bn | 74.74% |
| 4 | Merck | 367.41 Bn | 321.79 Bn | 12.21 Bn | 73.54% |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 78.02% |
| 6 | Astrazeneca | 261.20 Bn | 234.88 Bn | 12.86 Bn | 83.60% |
| 7 | Amgen | 235.55 Bn | 190.95 Bn | 7.24 Bn | 72.04% |
| 8 | Gilead Sciences | 190.64 Bn | 164.84 Bn | 6.22 Bn | 79.76% |
| 9 | Pfizer | 169.29 Bn | 115.93 Bn | 10.94 Bn | 72.78% |
| 10 | Immucell | 95.91 Mn | 73.35 Mn | 2.44 Mn | 33.92% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 33.92% |
| Dec 31, 2025 | 38.16% |
| Sep 30, 2025 | 42.92% |
| Jun 30, 2025 | 43.72% |
| Mar 31, 2025 | 41.58% |
| Dec 31, 2024 | 36.53% |
| Sep 30, 2024 | 26.34% |
| Jun 30, 2024 | 22.48% |
| Mar 31, 2024 | 31.63% |
| Sep 30, 2023 | 23.48% |
| Jun 30, 2023 | 29.55% |
| Mar 31, 2023 | 8.73% |
| Dec 31, 2022 | 25.37% |
| Sep 30, 2022 | 38.49% |
| Jun 30, 2022 | 44.22% |
| Mar 31, 2022 | 51.72% |
| Dec 31, 2021 | 47.04% |
| Sep 30, 2021 | 46.96% |
| Jun 30, 2021 | 45.67% |
| Mar 31, 2021 | 39.01% |
API Access
Immucell Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=ICCC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "ICCC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=ICCC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();